Januka Budhathoki-Uprety received her PhD degree in chemistry from North Carolina State University in 2012. Her doctoral research work focused on the synthesis of helical polymers. Upon completion of her PhD, she joined the laboratory of Daniel Heller at Memorial Sloan Kettering as a Research Fellow. In her current role, she is developing new molecular probes using polymers and polymeric nanoparticles for imaging, diagnostic, and therapeutic applications.
Kelly Henry obtained her PhD in chemistry at Syracuse University in 2015. Her doctoral work focused on the structure-activity relationships and appetite-regulating effects of neuropeptides, using vitamin B12 as a drug delivery vehicle. In July 2015, she joined the lab of Jason Lewis at Memorial Sloan Kettering Cancer Center. She is currently working on interrogating oncogenic pathways and assessing target engagement using protein-based radiotracers via molecular imaging in cancer.
Susanne Kossatz obtained her PhD degree in 2013 from the Jena University Hospital in Germany. During her thesis she worked on optical imaging of colorectal cancer using small molecule fluorescence probes. During her first postdoctoral position, also at the Jena University Hospital, her research focused on magnetic nanoparticles for hyperthermia treatment and imaging of pancreatic and breast cancer in a European Union research project. In 2014, she started working at Memorial Sloan Kettering as a postdoctoral research fellow in the laboratories of Thomas Reiner and Wolfgang Weber, focusing on the exploration of new applications for novel molecular imaging probes.
Brian Madajewski received his PhD in cancer cell biology from West Virginia University in 2016. His doctoral research work focused on the role of oxidative stress regulators in the promotion of non-small cell lung cancer and the maintenance of cancer stem cells. Following completion of his doctoral work, he joined the lab of Michelle Bradbury at Memorial Sloan Kettering as a postdoctoral research fellow. His current work focuses on the translational research of FDA-approved C dots in cancer theranostics.
Patricia Pereira obtained her PhD in Medicinal Chemistry from the University of Aveiro, Portugal in October 2016. During her doctoral thesis she developed new photosensitizers by conjugating them with specific galactose motifs and validated them in the treatment of bladder cancer by Photodynamic Therapy. In November 2016, she joined the laboratory of Dr. Jason Lewis at Memorial Sloan Kettering Cancer Center (MSKCC). In her current role, she aims to modulate endocytic trafficking systems for improved immunoPET and radioimmunotherapy of Bladder and Gastric Tumors. In addition to Dr. Lewis, Dr. Jeremy Durack and Dr. Yelena Y. Janjigian have been kind to serve as a co-mentors in her research project, who will be instrumental to the potential translation of the project in a clinical setting.
Sai Kiran Sharma obtained his PhD in Pharmaceutical Sciences from the University of Alberta, Canada in 2014. His doctoral thesis work focused on the development and testing of immunoPET probes for the molecular imaging of epithelial ovarian cancer. In September 2014, he joined the laboratories of Dr. Jason Lewis at Memorial Sloan Kettering Cancer Center and Dr. Brian Zeglis at Hunter College of the City University of New York. In working between the two labs, he aims to develop antibody-based theranostic agents for the molecular imaging and therapy of ovarian cancer.
Sui-Seng Tee received his bachelor’s degree and PhD degree from the University of Cambridge in England, where he worked on imaging reporter genes. He then moved to Stanford University for his postdoctoral training, developing self-assembling probes for measuring apoptosis as well as metabolic imaging. Sui-Seng moved to Kayvan Keshari’s laboratory at Memorial Sloan Kettering in 2014 and is currently investigating the interplay between signaling pathways and imaging cancer metabolism using hyperpolarized MRI.
Brandon Carney obtained his bachelor’s degree in 2012 from St. John’s College in Annapolis, Maryland. He then accepted a position as a postbaccalaureate research assistant at Los Alamos National Laboratory, where he worked on lanthanide and actinide chemistry in the laboratories of Drs. George Goff and Wolfgang Runde. In 2013, he accepted a graduate student position at the City University of New York and joined Hunter College as part of its Integrative Graduate Education and Research Traineeship radiochemistry program. He now works in the laboratory of Thomas Reiner, where he develops novel PET and multimodal imaging probes.
Brendon Cook graduated magna cum laude in 2014 from Alfred University in Alfred, New York, with bachelor’s degrees in both biology and chemistry. While at Alfred, he developed an interest in nuclear medicine at the American Chemical Society’s National Nuclear Chemistry Summer School at Brookhaven National Laboratory. He later joined the Integrative Graduate Education and Research Traineeship radiochemistry program at Hunter College and the Graduate Center at the City University of New York. Brendon now works in the labs of Brian Zeglis at Hunter College and Jason Lewis at Memorial Sloan Kettering and is pursuing a PhD degree in chemistry, investigating novel methods of integrating nanomedicine with molecular imaging for cancer imaging and therapy.
Jiye is a PhD student under the supervision of Prof. Ulijn and Prof. Maria Contel of Brooklyn College and Dr. Daniel Heller at MSKCC. Her research focuses on the synthesis of medicinal organometallic compounds and the delivery of those drugs using enzyme responsive short peptides for anti-cancer therapeutics. Prior to starting graduate school, she received her B.S. in Chemistry from SUNY Stony Brook University and was an employee of the Product Safety and Toxicology Department of The Estee Lauder Companies in Melville, NY.